Author： Doggrell S.A. Brown L.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.5, 2001-05, pp. : 943-954
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Spironolactone: Gynaecomastia: case report
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :
Access to resources
Recommend
Spironolactone: predictors of harmful effects
Inpharma, Vol. 1, Iss. 1414, 2003-01 ,pp. :
Spironolactone sinks resistant hypertension
Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. :
Spironolactone: extrapolation of trial results inappropriate?
Reactions Weekly, Vol. 1, Iss. 1014, 2004-01 ,pp. :
Spironolactone "safer first-line" therapy for hypertension
Reactions Weekly, Vol. 1, Iss. 1254, 2009-01 ,pp. :